Newark Venture Partners is a venture capital and private equity firm investing in early stage business to business companies that is headquartered in Newark, New Jersey and was founded in 2015 by Daniel Bork, Don Katz, and Tom Wisniewski. Notable investments made by the company include: CircleLink Health, Augmented Review, Designity, Vetty, Inpensa, UpChannel, Bixby, and StrongArm TechnologiesStrongArm Technologies.
Abnormal Security was founded in 2018 by Evan Reiser - CEO, Sanjay Jeyakumar - CTO, Jeshua Bratman - Head of Machine Learning, and Founding Engineers - Dmitry Chechik and Abhijit Bagri. The headquarters is located in San Francisco, California. The Abnormal Security platform shields companies from targeted email attacks. Abnormal Behavior Technology (ABX) mirrors the identity of company employees and external senders. It profiles relationships, assesses each organization and examines email content to halt attacks that precede financial damage, account takeover and organizational mistrust. They are backed by Greylock Partners, a venture capital firm based in Silicon ValleySilicon Valley.
As of November 2019 venBio has made 42 investments, has 20 companies in its portfolio, and has made 18 exits. Notable investments made by venBio include: Inbrace, Neurogastrix, Swfit Health Systems, Aeovian Pharmaceuticals, Checkmate Pharmaceuticals, Turning Point TherapeuticsTurning Point Therapeutics, Precision BioSciences, Akero Therapeutics, Oncobiologics, and Corvus Pharmaceuticals.